3 terminated. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Terminated 3 |
Follow Arteriovenous Malformations: new trials by email Literature Review of Arteriovenous Malformations trials Research Report on Arteriovenous Malformations
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The LIPMAT Study: Liposomal Prednisolone to Improve Hemodialysis Fistula Maturation PEG-liposomal prednisolone sodium phosphate, Placebo - Renal Dialysis, Hemodynamics | Phase 2 | Terminated | Leiden University Medical Center | 30 | 2015-11-01 | 2018-09-18 |
| Efficacy and Local Tolerability of Topically Applied Heparin on the Suitability of Newly Constructed Primary Arteriovenous Fistulas in Patients Planned for Haemodialysis Heparin 2,400 IU /ml Cutaneous Spray, Placebo Cutaneous Spray - Haemodialysis | Phase 2 | Terminated | Cyathus Exquirere Pharmaforschungsgmbh | 30 | 2011-07-01 | 2014-05-08 |
| Reducing Hemodialysis Catheter Use in Prevalent Hemodialysis Patients Protocolized approach to convert dialysis catheter to fistula - Hemodialysis | Phase 2 | Terminated | Dr. Lisa Miller | 3 | 2009-02-01 | 2014-04-17 |
Arteriovenous Fistula (3) · Neointima (1) · Renal Insufficiency, Chronic (1) · Vascular Remodeling (1)
Cardiovascular Abnormalities (3) · Cardiovascular Diseases (3) · Congenital Abnormalities (3) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3) · Fistula (3) · Pathological Conditions, Anatomical (3) · Pathological Conditions, Signs and Symptoms (3) · Vascular Diseases (3) · Vascular Fistula (3) · Vascular Malformations (3) · Pathologic Processes (2) · Chronic Disease (1) · Disease Attributes (1) · Female Urogenital Diseases (1)
Heparin (1)
Cyathus Exquirere Pharmaforschungsgmbh (1) · Dr. Lisa Miller (1) · Leiden University Medical Center (1)
Austria (1) · Canada (1) · Netherlands (1)
Joris I Rotmans, MD PhD (1) · Lisa M Miller, MD (1)